Cannabinoid receptors in microglia of the central nervous system: Immune functional relevance

Journal of Leukocyte Biology

Volumn 78, Issue 6, 2005, Pages 1192-1197

  Cabral, G A ^a   Marciano Cabral, F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Brain immune modulation; Cytokines; Marijuana; Nitric oxide

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CHEMOKINE; CYTOKINE;

ACCESSORY CELL; ANIMAL CELL; CELL ACTIVITY; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; EFFECTOR CELL; HOST RESISTANCE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MICROGLIA; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE REPAIR;

ANIMALS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM; ENCEPHALITIS; GLIOSIS; HUMANS; IMMUNE SYSTEM; MICROGLIA; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID;

ANIMALIA; CANNABIS SATIVA;

EID: 28844487137     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0405216     Document Type: Conference Paper

References (52)

1. Nahas, G., Latour, C. (1992) The human toxicity of marijuana. Med. J. Aust. 156, 495-497.
2. Turner, C. E., Elsohly, M. A., Boeren, E. G. (1980) Constituents of Cannabis saliva L. XVII. A review of the natural constituents. J. Nat. Prod. 43, 169-234.
3. Wing, D. R., Leuschner, J. T. A., Brent, G. A., Harvey, D. J., Paton, W. D. M. (1985) Quantitation of in vivo membrane-associated Δ-1- tetrahydrocannabinol and its effect on membrane fluidity. In Marihuana '84: Proceedings of the Oxford Symposium on Cannabis (D. J. Harvey, ed.), Oxford, UK, IRL.
4. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
5. Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., Martin, B. R. (1993) Cannabinoid structure-activity relationships: correlation of receptor binding in vivo activities. J. Pharmacol. Exp. Ther. 265, 218-226.
6. Munro, S., Thomas, K. L., Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
7. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61.
8. Hewlett, A. C., Qualy, J. M., Khachatrian, L. L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307-313.
9. Mackie, K., Hille, B. (1992) Cannabinoids inhibit N-type calcium channels in neurobalstoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
10. 35]GTPγS autoradiography in rat brain. J. Neurosci. 16, 8057-8066.
11. 2 receptors. Mol Pharmacol. 48, 443-450.
12. Breivogel, C. S., Griffin, G., Di Marzo, V., Martin, B. R. (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 60, 155-163.
13. Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., Martin, B. R. (2000) Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75, 2434-2444.
14. Jarai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., Razdan. R. K., Zimmer, A., Kunos, G. (1999) Cannabinoid induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. USA 96, 14136-14141.
15. Mann, P. E. G., Cohen, A. B., Finley, T. N., Ladman, A. J. (1971) Alveolar macrophages. Structural and functional differences between non-smokers and smokers of marijuana in vitro. Lab. Invest. 25, 111-120.
16. Raz, A., Goldman. R. (1976) Effect of hashish compounds on mouse peritoneal macrophages. Lab. Invest. 34, 69-76.
17. Cabral, G. A., Dove Pettit, D. A. (1998) Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J. Neuroimmunol. 83, 116-123.
18. Aloisi, F., Ria, F., Penna, G., Adorini, L. (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160, 4671-4680.
19. Gehrmann, J., Matsumoto, Y., Kreutzberg, G. W. (1995) Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 20, 269-287.
20. Ling, E. A., Wong, W. C. (1993) The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7, 9-18.
21. Stoll, G., Jander, S. (1999) The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58, 233-247.
22. Benveniste, E. N. (1997) Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75, 165-173.
23. Kreutzberg, G. W. (1995) Microglia, the first line of defense in the brain pathologies. Arzneimittelforschung 45, 357-360.
24. Kreutzberg, G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
25. Leong, S., Ling, E. (1992) Ameboid and ramified microglia: their interrelationship and response to brain injury. Glia 6, 39-47.
26. Perry, S. W. (1990) Organic mental disorders caused by HIV: update on early diagnosis and treatment. Am. J. Psychiatry 147, 696-710.
27. Streit, W. J., Graeber, M. B., Kreutzberg, G. W. (1988) Functional plasticity of microglia: a review. Glia 1, 301-307.
28. Matsumoto, Y., Ohmori, K., Fujiwara, M. (1992) Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J. Neuroimmunol. 37, 23-33.
29. Rogers, J., Luber-Nardo, J., Styren, S. D., Civin, W. H. (1988) Expression of immune system-associated antigens by cells of the central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9, 339-349.
30. McGeer, P. L., Itagaki, S., Boyes, B. E., McGeer, E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
31. Dickson, D. W., Mattiace, L. A., Kure, K., Hutchins, K., Lyman, W. D., Brosnan, C. F. (1991) Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest. 64, 135-156.
32. Merrill, J. E., Chen, I. S. Y. (1991) HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5, 2391-2397.
33. Spencer, D. C., Price, R. W. (1992) Human immunodeficiency virus and the central immune system. Annu. Rev. Microbiol. 46, 655-693.
34. Giulian, D., Baker, T. J., Shih, L. N., Lachman, L. B. (1986) IL-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594-604.
35. Reid, D. M., Perry, V., Andersson, P., Gordon, S. (1993) Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience 56, 529-533.
36. Waksman, Y., Olson, J. M., Carlisle, S. J., Cabral, G. A. (1999) The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharmacol. Exp. Ther. 288, 1357-1366.
37. Carayon, P., Marchand, J., Dussossoy, D., Derocq, J. M., Jbilo, O., Bord, A., Bouaboula, M., Galiegue, S., Mondiere, P., Penarier, G., Fur, G. L., Defrance, T., Casellas, P. (1998) Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92, 3605-3615.
38. Showalter, V. M., Compton, D. R., Martin, B. R., Abood, M. E. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2); identification of cannabinoid receptor subtype selective agonists. J. Pharmacol. Exp. Ther. 278, 989-999.
39. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J. C., Le Fur, G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
40. Wiley, J. L., Barrett, R. L., Lowe, J., Balster, R. L., Martin, B. R. (1995) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34, 669-676.
41. Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J., Seltzman, H. H. (1998) Comparative receptor binding analyses of cannabinoid agonists and antagonists. J. Pharmcol. Exp. Ther. 285, 285-292.
42. Mechoulam, R., Feigenbaum, J. J., Lander, N., Segal, M., Jarbe, T. U., Hiltunen, A. J., Consroe, P. (1988) Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia 44, 762-764.
43. 8-tetrahydrocannabinol- dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Neuropharmacology 29, 161-165.
44. Pertwee. R. G. (1999) Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6, 635-664.
45. Hewlett. A. C., Fleming, R. M. (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26, 532-538.
46. Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., Portier, M., Shire, D., Breliere, J. C., Le Fur, G. L. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmcol. Exp. Ther. 284, 644-650.
47. McCoy, K. L., Gainey, D., Cabral, G. A. (1995) Δ-9- Tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273, 1216-1223.
48. McCoy, K. L., Matveyeva, M., Carlisle, S. J., Cabral, G. A. (1999) Cannabinoid inhibition of the intact lysozyme by macrophages: evidence for CB2 receptor participation. J. Pharmacol. Exp. Ther. 289, 1620-1625.
49. Benito, C., Nunez, E., Tolon, R. M., Carrier, E. J., Rabano, A., Billard, C. J., Romero, J. (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci. 23, 11136-11141.
50. Marciano-Cabral, F., Cabral, G. A. (2003) Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev. 16, 273-307.
51. Puffenbarger, R. A., Boothe, A. C., Cabral, G. A. (2000) Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia 29, 58-69.
52. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., Stella, N. (2003) Nonpsychotropic cannabinoid receptors regulate cell migration. J. Neurosci. 23, 1398-1405.